Celanese (CE) — insider trading
Materials · NYSE
Celanese (CE) has 32 reported SEC Form 4 insider transactions in our data, including 5 open-market purchases among the most recent 32 (latest 2026-08-14).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Kyrish Chuck | Officer (SVP & CFO) | Open-market purchase | 800 | $45.51 | $36.4K | Form 4 |
| 2026-08-14 | Kyrish Chuck | Officer (SVP & CFO) | Open-market purchase | 100 | $45.51 | $4.6K | Form 4 |
| 2026-08-14 | Kyrish Chuck | Officer (SVP & CFO) | Open-market purchase | 1,400 | $45.53 | $63.7K | Form 4 |
| 2026-08-11 | Duffie Ashley B | Officer (SVP & GC) | Open-market purchase | 600 | $45.60 | $27.4K | Form 4 |
| 2026-08-11 | Murray Mark Christopher | Officer (SVP - Acetyls) | Open-market purchase | 2,153 | $45.52 | $98.0K | Form 4 |
| 2026-08-10 | Hill Kathryn | Director | Grant / award / vesting (derivative) | 1 | $44.46 | $34 | Form 4 |
| 2026-08-10 | GALANTE EDWARD G | Director | Grant / award / vesting (derivative) | 5 | $44.46 | $204 | Form 4 |
| 2026-08-10 | GALANTE EDWARD G | Director | Grant / award / vesting | 1,930 | — | $0 | Form 4 |
| 2026-08-10 | Rucker Kim K.W. | Director | Grant / award / vesting (derivative) | 9 | $44.46 | $387 | Form 4 |
| 2026-08-10 | Kissire Deborah J. | Director | Grant / award / vesting (derivative) | 6 | $44.46 | $279 | Form 4 |
| 2026-05-11 | GALANTE EDWARD G | Director | Grant / award / vesting (derivative) | 3 | $59.55 | $204 | Form 4 |
| 2026-05-11 | GALANTE EDWARD G | Director | Grant / award / vesting | 4,676 | — | $0 | Form 4 |
| 2026-05-11 | Kuehn Christopher J | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | Hill Kathryn | Director | Grant / award / vesting (derivative) | 1 | $59.55 | $34 | Form 4 |
| 2026-05-11 | Hill Kathryn | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | Rucker Kim K.W. | Director | Grant / award / vesting (derivative) | 5 | $59.55 | $286 | Form 4 |
| 2026-05-11 | Rucker Kim K.W. | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | Kissire Deborah J. | Director | Grant / award / vesting (derivative) | 3 | $59.55 | $178 | Form 4 |
| 2026-05-11 | Kissire Deborah J. | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | MOORTHY GANESH | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | Koenig Michael | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | Noonan Anne P | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-11 | Chinn Bruce E. | Director | Grant / award / vesting | 2,975 | — | $0 | Form 4 |
| 2026-05-09 | Kuehn Christopher J | Director | Grant / award / vesting (derivative) | 3,376 | — | $0 | Form 4 |
| 2026-05-09 | Kuehn Christopher J | Director | Disposition to the issuer | 3,376 | — | — | Form 4 |
| 2026-05-09 | Rucker Kim K.W. | Director | Grant / award / vesting (derivative) | 3,376 | — | $0 | Form 4 |
| 2026-05-09 | Rucker Kim K.W. | Director | Disposition to the issuer | 3,376 | — | — | Form 4 |
| 2026-05-09 | Kissire Deborah J. | Director | Grant / award / vesting (derivative) | 3,376 | — | $0 | Form 4 |
| 2026-05-09 | Kissire Deborah J. | Director | Disposition to the issuer | 3,376 | — | — | Form 4 |
| 2026-05-09 | Koenig Michael | Director | Shares withheld for taxes / exercise cost | 1,013 | $57.51 | $58.3K | Form 4 |
| 2026-03-10 | Kissire Deborah J. | Director | Grant / award / vesting (derivative) | 4 | $50.67 | $178 | Form 4 |
| 2026-03-10 | Rucker Kim K.W. | Director | Grant / award / vesting (derivative) | 6 | $50.67 | $285 | Form 4 |
Ask the chat about CE's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Celanese (CE).
Last updated 2026-08-14 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.